Covid Jab Maker BioNTech To Build SE Asia Manufacturing Site


Source: dnyuz.com dnyuz.com

Key Topics in this News Article:

News Snapshot:

1.5k VIEWS Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of the site will start this year, and it could become operational by 2023, the German company said in a statement. “With this planned mRNA production facility, we will increase our overall network capacity and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world,” said BioNTech chief executive Ugur Sahin. The vaccine produced by BioNTech jointly with Pfizer of the United...